Companies
LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test
The LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete test is a laboratory-use assay run on open RT-PCR instruments.
Top Five Articles on 360Dx Last Week: Roche Mass Spec Plans, Jana Care Collaboration; and More
Last week, readers were most interested in Roche's planned launch of its mass spec clinical analyzer in a market that has proven challenging for other vendors.
Through its OEM partner, the company secured NMPA registrations for IVD use in China for its bone marrow aspirate DNA exaction kit and its DNA staining reagents.
MDxHealth Prices $40M Public Offering
The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million.
In Brief This Week: Meridian Bioscience, BARDA, HHS, Oncocyte, GeneDx, More
News items for the week of Jan. 30, 2023.
Feb 1, 2023
Feb 1, 2023
360Dx Top 30 Starts the Year up 1 Percent
Jan 31, 2023
Jan 25, 2023